dwp-05195
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00969787)
Timeline
Indications
Mechanism of action
- Vanilloid receptorANTAGONIST
TRPV1 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
FC(F)(F)c1cccnc1-c1ccc(-c2nc3ccc(Br)cc3[nH]2)nc1- Mol. weight
- 419.2 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314400 ↗
- ChEMBLCHEMBL3545229 ↗
Also known as
- dwp05195
- dwp05195
- dwp-05195
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01557010 | Phase 2 | Mar 1, 2012 | Daewoong Pharmaceutical Co. LTD. |
| NCT01094834 | Phase 1 | Apr 1, 2010 | Daewoong Pharmaceutical Co. LTD. |
| NCT00969787 | Phase 1 | Apr 1, 2009 | Daewoong Pharmaceutical Co. LTD., Seoul National University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daewoong Pharmaceutical Co. LTD. | For profit | 3 | 3 | 2 | 2009 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1